CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in EDIT — Editas Medicine, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,127,475
+$498,400 QoQ
Shares Held
861,326
+8.4% QoQ
Ownership
0.880%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.97677998806492.ToString("F0")%
Shared 0.ToString("F0")%
None 0.023220011935086132.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. EDIT ranks #169 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in EDIT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,127,475 | 861,326 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,629,075 | 794,671 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,706,443 | 779,955 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,543,311 | 701,505 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $794,479 | 684,896 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $772,476 | 608,249 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,104,924 | 617,280 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,424,907 | 733,385 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,352,224 | 856,095 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,929,082 | 684,016 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,373,919 | 688,964 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,265,362 | 518,270 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,721,787 | 513,350 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,521,562 | 509,759 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,113,341 | 499,456 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,759,175 | 486,828 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,463,857 | 497,574 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,871,068 | 484,786 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $19,516,573 | 475,087 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $27,931,166 | 493,135 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $20,203,596 | 481,038 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $28,933,555 | 412,688 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,438,715 | 407,652 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,646,148 | 393,717 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $6,669,939 | 336,356 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||